Singapore Paincare Holdings (SGX:FRQ) Risk Assessment

View and export this data going back to 2020. Start your Free Trial

What is Singapore Paincare Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Singapore Paincare Holdings is: High Risk: Good fundamentals, beware of shrinking business.

Competitive Comparison of Singapore Paincare Holdings's Risk Assessment

For the Medical Care Facilities subindustry, Singapore Paincare Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore Paincare Holdings's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Paincare Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Singapore Paincare Holdings's Risk Assessment falls into.

Singapore Paincare Holdings (SGX:FRQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Singapore Paincare Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Singapore Paincare Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore Paincare Holdings (SGX:FRQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Paincare Holdings Ltd (SGX:FRQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242

Website

https://www.sgpaincareholdings.com

Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, and primary care and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company derives its revenue from Singapore.

Singapore Paincare Holdings (SGX:FRQ) Headlines

No Headlines